Global Acute Ischemic Stroke Diagnosis and Treatment Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Assumptions
1.4 List of Abbreviations

Chapter 2 Executive Summary
2.1 Overview
2.2 Market Snapshot: Global Acute Ischemic Stroke Diagnosis and Treatment Market (2018 & 2026)
2.3 Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Types , 2018 (USD Million)
2.4 Comparative Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography, 2018 and 2026 (Value %)

Chapter 3 Market Overview
3.1 Overview
3.2 Event Impact Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market
3.3 Market Drivers
3.3.1 Rising number of acute stroke patients aiding the growth of diagnosis and treatment market
3.3.2 Technological innovations in diagnostic and surgical devices boosts market growth
3.4 Restraints
3.4.1 Alternative treatments and high cost are posing a threat for the growth of the market
3.5 Opportunities
3.5.1 Huge potential patient in Asia-Pacific creates opportunity for acute ischemic stroke product developers record high growth in revenue
3.6 Value Chain Analysis
3.7 Porter’s Five Force Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market
3.7.1 Bargaining power of suppliers
3.7.2 Bargaining power of buyers
3.7.3 Threat of new entrants
3.7.4 Threat of substitutes
3.7.5 Competitive rivalry
3.8 Market Attractiveness Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography
3.9 Competitive Landscape
3.9.1 Market Share Analysis by Key Players, 2018 (Value %)

Chapter 4 Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type
4.1 Overview
4.1.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Diagnostic Types, 2016 – 2026 (USD Million)
4.2 Computed Tomography
4.2.1 Global Computed Tomography Market Revenue, 2016 – 2026 (USD Million)
4.3 Magnetic Resonance Imaging
4.3.1 Global Magnetic Resonance Imaging Market Revenue, 2016 – 2026 (USD Million)
4.4 Ultrasound
4.4.1 Global Ultrasound Market Revenue, 2016 – 2026 (USD Million)
4.5 Cerebral angiography
4.5.1 Global Cerebral Angiography Market Revenue, 2016 – 2026 (USD Million)
4.6 Nuclear Imaging
4.6.1 Global Nuclear Imaging Market Revenue, 2016 – 2026 (USD Million)
4.7 Others
4.7.1 Global Others Market Revenue, 2016 – 2026 (USD Million)

Chapter 5 Acute Ischemic Stroke Diagnosis and Treatment Market by, Surgery Type
5.1 Overview
5.1.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Surgery Type, 2016 – 2026 (USD Million)
5.2 Carotid Endarterectomy
5.2.1 Global Carotid Endarterectomy Market Revenue, 2016 – 2026 (USD Million)
5.3 Angioplasty
5.3.1 Global Angioplasty Market Revenue, 2016 – 2026 (USD Million)
5.4 Endovascular Mechanical Thrombectomy
5.4.1 Global Endovascular Mechanical Thrombectomy Market Revenue, 2016 – 2026 (USD Million)

Chapter 6 Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography
6.1 Overview
6.1.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Geography, 2016 – 2026 (USD Million)
6.2 North America
6.2.1 North America Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2016 – 2026 (USD Million)
6.3 Europe
6.3.1 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2016 – 2026 (USD Million)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2016 – 2026 (USD Million)
6.5 Rest of the World
6.5.1 RoW Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2016 – 2026 (USD Million)

Chapter 7 Recommendations
7.1 Rigorous research and development initiatives for innovative products
7.2 Investing in emerging economies

Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Covidien plc
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent Developments
8.3 Johnson & Johnson (Cordis Corporation)
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 Penumbra, Inc.
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.5 Recent Developments
8.5 Philips Healthcare
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 GE Healthcare
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Developments
8.7 Hitachi, Ltd.
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 Siemens Healthcare
8.8.1 Company Overview
8.8.2 Financial overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 Stryker Corporation (Concentric Medical, Inc.)
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments

Report Details

  • Report Code:28887
  • Category:Healthcare
  • No. of Pages:140
  • Format:PDF/PPT/Excel
  • Published:August 2019
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers